Evidence map›Paper›PMID 36633126›Full record

ArticleMolecular medicine reports2023

Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes.

Naoto Uramaru, Azusa Kawashima, Makoto Osabe, Toshiyuki Higuchi

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Raspberry Ketone Accumulation inJournal of agricultural and food chemistry · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Naoto UramaruDivision of Pharmaceutical Health Biosciences, Nihon Pharmaceutical University, Saitama 362‑0806, Japan.
Azusa KawashimaDivision of Pharmaceutical Health Biosciences, Nihon Pharmaceutical University, Saitama 362‑0806, Japan.
Makoto OsabeDivision of Pharmaceutical Health Biosciences, Nihon Pharmaceutical University, Saitama 362‑0806, Japan.
Toshiyuki HiguchiDivision of Pharmaceutical Health Biosciences, Nihon Pharmaceutical University, Saitama 362‑0806, Japan.
Nihon Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is a serious medical condition worldwide, and a major risk factor for type 2 diabetes, metabolic syndrome, cancer and cardiovascular disease. In addition to changes in dietary habits and physical activity, consuming supplements to maintain good health and prevent obesity is important in modern society. Raspberry ketone (RK) is a natural phenolic ketone found in the European red raspberry (

Indexed as

AdipocytesAdipogenesisAnti-Obesity AgentsButanols3T3-L1 CellsAnimalsButanonesCCAAT-Enhancer-Binding Protein-alphaHumansMiceObesityPPAR gammaAnti-Obesity AgentsButanolsButanonesCCAAT-Enhancer-Binding Protein-alphaPPAR gammaraspberry ketonerhododendrol3T3‑L1 cellsadipocytemetabolic activationRKROH

Identifiers

PMID36633126
PMCPMC9879071
OpenAlexW4315646820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.